• FirefoxInstall the new Firefox »
  •  Dow Down0.13% Nasdaq Down0.10%

    Hemispherx Biopharma, Inc. (HEB)

    -ASE
    0.24 Up 0.00(0.99%) 10:18AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (16,225) (17,354) (9,015)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation867  683  630  
    Adjustments To Net Income1,348  1,303  (1,979)
    Changes In Accounts Receivables -   -   -  
    Changes In Liabilities(2,784)2,611  625  
    Changes In Inventories -  (579)(110)
    Changes In Other Operating Activities(36)200  (247)
    Total Cash Flow From Operating Activities (16,830) (13,136) (10,096)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(898)(5,755)(1,802)
    Investments23,479  (10,107)10,695  
    Other Cash flows from Investing Activities(313)(205)(238)
    Total Cash Flows From Investing Activities 22,268   (16,067) 8,655  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock249  23,003   -  
    Net Borrowings(45)(47)(71)
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities (6,847) 28,312   1,624  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents (1,409) (891) 183  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.